➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Colorcon
Express Scripts
Johnson and Johnson
McKesson

Last Updated: August 1, 2021

DrugPatentWatch Database Preview

ALOCRIL Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Alocril patents expire, and what generic alternatives are available?

Alocril is a drug marketed by Allergan and is included in one NDA.

The generic ingredient in ALOCRIL is nedocromil sodium. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the nedocromil sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Alocril

A generic version of ALOCRIL was approved as nedocromil sodium by AKORN on August 22nd, 2012.

  Try it Free

US Patents and Regulatory Information for ALOCRIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan ALOCRIL nedocromil sodium SOLUTION/DROPS;OPHTHALMIC 021009-001 Dec 8, 1999 AT RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ALOCRIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan ALOCRIL nedocromil sodium SOLUTION/DROPS;OPHTHALMIC 021009-001 Dec 8, 1999 ⤷  Try it Free ⤷  Try it Free
Allergan ALOCRIL nedocromil sodium SOLUTION/DROPS;OPHTHALMIC 021009-001 Dec 8, 1999 ⤷  Try it Free ⤷  Try it Free
Allergan ALOCRIL nedocromil sodium SOLUTION/DROPS;OPHTHALMIC 021009-001 Dec 8, 1999 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Colorcon
Express Scripts
Johnson and Johnson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.